Literature DB >> 29441646

bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM)-the active metabolite of the laxatives bisacodyl and sodium picosulfate-enhances contractility and secretion in human intestine in vitro.

D Krueger1, I E Demir2, G O Ceyhan2, F Zeller3, M Schemann1.   

Abstract

BACKGROUND: Stimulant laxatives are widely used to treat constipation. We investigated in human small and large intestinal preparations the effects of bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), the active metabolite of the laxatives bisacodyl and sodium picosulfate on smooth muscle tone and epithelial secretion.
METHODS: Circular and longitudinal muscle tone of small or large intestinal preparations were recorded with isometric force transducers. Epithelial ion flux (ISC ) and tissue resistance was measured with Ussing chamber technique after apical and basolateral BHPM application to large intestinal mucosa/submucosa preparations. Studies were performed in macroscopically normal specimens from 79 patients. KEY
RESULTS: BHPM concentration-dependently (0.5-5 μM) increased the tone of circular and longitudinal muscle from small to large intestine. The effect was strongest in large intestinal longitudinal muscle and smallest in small intestinal circular muscle. Increase in muscle tone was prevented by the L-type Ca++ channel blocker nifedipine but insensitive to the nerve blocker tetrodotoxin. Apical or basolateral BHPM concentration-dependently decreased or increased ISC, respectively. The KCa 1.1 (BK) channel blocker iberiotoxin reversed apical ISC decrease whereas tetrodotoxin reversed basolateral ISC increase. BHPM had no effect on tissue resistance or nerve-mediated secretory or muscle response with one exception: at the highest concentration basolateral BHPM reduced nerve-mediated secretion. CONCLUSIONS AND INTERFERENCES: BHPM enhanced mucosal secretion and muscle contractility. Results suggested that the laxative effect of BHPM was a consequence of the increase in muscle tone as well as an increased K+ secretion when acting luminally and a nerve-driven Cl- and HCO3- secretion once acting basolaterally after absorption.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  bis-(p-hydroxyphenyl)-pyridyl-2-methane; laxative; motility; secretion

Mesh:

Substances:

Year:  2018        PMID: 29441646     DOI: 10.1111/nmo.13311

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  5 in total

1.  Bisacodyl Limits Chikungunya Virus Replication In Vitro and Is Broadly Antiviral.

Authors:  Natalie J LoMascolo; Yazmin E Cruz-Pulido; Bryan C Mounce
Journal:  Antimicrob Agents Chemother       Date:  2022-06-02       Impact factor: 5.938

Review 2.  Treatment of Gastrointestinal Disorders-Plants and Potential Mechanisms of Action of Their Constituents.

Authors:  Szilvia Czigle; Silvia Bittner Fialová; Jaroslav Tóth; Pavel Mučaji; Milan Nagy
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

Review 3.  Preclinical experimental models for assessing laxative activities of substances/products under investigation: a scoping review of the literature.

Authors:  Patiwat Kongdang; Dumnoensun Pruksakorn; Nut Koonrungsesomboon
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

Review 4.  The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.

Authors:  Yong Ling; Zhi-You Hao; Dong Liang; Chun-Lei Zhang; Yan-Fei Liu; Yan Wang
Journal:  Drug Des Devel Ther       Date:  2021-10-13       Impact factor: 4.162

Review 5.  Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation.

Authors:  Maura Corsetti; Sabine Landes; Robert Lange
Journal:  Neurogastroenterol Motil       Date:  2021-03-09       Impact factor: 3.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.